glp 1 meds for diabetes GLP-1 Drugs: Fighting and Weight Gain💊 - General Health Canada approves first GLP-1

Description

These findings are the first to establish a functional role for GLP-1-producing NTSVTA projections in cocaine seeking and support the hypothesis that endogenous GLP-1R-expressing circuits are important anti-craving pathways that when activated reduce drug seeking during abstinence

Global GLP-1 Receptor Agonist Market Recent Developments: 2025: Eli Lilly's once-daily oral GLP-1 agonist Orforglipron completed Phase III trials, delivering meaningful weight loss and strong blood-glucose (A1C) reduction

Williams A, Morgan J, Johnson A, Bates S, Pople I, Norton S

Preclinical studies have shown that GIP may reduce body weight by reducing food intake and increasing energy consumption, and in combination with GLP-1 receptor agonists, may have a greater effect on patients' blood glucose and body weight